MEETING UPDATE

In accordance with the CDC's guidance, The National Lipid Association has come to the decision to reschedule the NLA 2020 Scientific Sessions to December 13-16, 2020.  This will be a unique meeting pattern for us, kicking off the Opening Session on Sunday, December 13, and wrapping up the conference on Wednesday, December 16 (with preconference courses taking place Saturday and Sunday, December 12-13).

Although we are disappointed that the Scientific Sessions cannot be held as originally planned in June, we look forward to delivering the most valuable and timely education to healthcare professionals like you who are dedicated to the management of dyslipidemia. If you have any questions, please do not hesitate to contact us at meetings@lipid.org or 904-998-0854. Please continue to monitor our website regularly for updates regarding the NLA 2020 Scientific Sessions.

You may need to disable administrative overlay in your Drupal record

Edit Parent - VENUE (visibility Show)

Venue Information


Chicago Marriott Downtown Magnificent Mile 

540 N Michigan Avenue 
Chicago, IL 60611


Meeting Room Rate: $215/night plus tax

More about the venue

Delete VENUE

Edit Parent - SUPPORT (visibility Show)

Exhibit in Chicago


Interested in educating our attendees about your products, services,and patient programs? Sign up to exhibit at the NLA's largest conference of the year! Learn more in our Exhibit and Sponsorship Prospectus, available soon.

Contact Kristen Lauer, NLA Exhibits Coordinator, at 904-309-6206 or klauer@lipid.org for questions. 



Delete SUPPORT

Edit Parent - SPECIAL EVENTS (visibility Show)

Foundation Event


Join the Foundation of the National Lipid Association

the 2020 annual fundraiser Gala

We are looking forward to hosting you at the beautiful International Museum of Surgical Science in Chicago during the NLA’s 2020 Scientific Sessions for an evening benefiting the Foundation and the patients and families we aim to serve.

In addition to a hearty family-style dinner, drinks, music, and a silent auction, our guests will have private access to the museum’s newest exhibit opening in March 2020, “Conquering Heart Disease: A Physician and Surgeon’s Perspective,” reviewing the evolution of the field of cardiovascular surgery and state-of-the-art technology in the 21st century.

Your presence and dedication to the Foundation will help to support our work in 2021, including health screenings in underserved populations, resources for rare disease patients, health awareness campaigns, and much more.

 

Tuesday, December 15, 2020

7:30 – 10:00PM

International Museum of Surgical Science

1524 N. Lake Shore Drive, Chicago, IL 60610

 

Ticket price - $165

Purchase your ticket online today!   

Symposia


    

Bridging the Gaps in Management of Familial Chylomicronemia Syndrome: A Team-Based Patient-Focused Approach

Sunday, December 13, 2020

1:45pm – Registration 

2:00 – 3:30pm – Program

Location: Chicago Marriott Magnificent Mile, General Session ballroom

 

Genetic dyslipidemias are often under-recognized and misdiagnosed in clinical practice leading to heightened burden of disease for patients and ineffective treatment strategies. Join our panel featuring a Familial Chylomicronemia Syndrome (FCS) patient advocate for a 1.5-hour CME symposium covering:

  • FCS case studies with a patient presentation
  • Making an Early Diagnosis with clinical & genetic confirmations
  • The importance of systematic communications between hospitalists, gastroenterologists, and lipid specialists
  • Clinical guidance on patient-led management and the future of pharmacotherapy for patients with FCS

Have questions for our panel? Stay for a robust panel discussion and Q&A segment with the audience. You will leave this session better able to demonstrate knowledge of the mechanisms and manifestations of FCS and counsel patients with FCS on comprehensive management plans.

 
 

Refreshments provided by the NLA

 

 

Dialogues from the Dais: Lipid Management in Clinical Medicine

Sunday, December 13, 2020

6:45pm – Registration and Dinner

7:00 – 8:30pm – Program

Location: Chicago Marriott Magnificent Mile, Northwestern Ballroom

 

This highly interactive CME-certified symposium will feature renown lipid experts who will address and discuss hot topics in lipid management. Topics include the remarkable clinical and biologic findings of omega-3 fatty acids to reduce ASCVD events, making sense of recent guidelines, more evidence on the role of triglyceride-rich lipoproteins in ASCVD, and new horizons for lipid management. This activity will provide the opportunity for the multidisciplinary faculty and symposium participants to work through complex issues and cases that challenge healthcare providers in caring for patients with elevated atherogenic cholesterol, many (or most) of whom have been sub-optimally managed.

Co-Hosted by Medtelligence

Dinner provided by the NLA

 
 

The Ever-Evolving Treatment Landscape of Lipid-Lowering Therapies

Monday, December 14, 2020

6:30am – Registration and Breakfast

7:00 – 9:00am – Program

Location: Chicago Marriott Magnificent Mile, Northwestern Ballroom

 
Co-Hosted by Medscape

Breakfast provided by the NLA

 

Genetic Dyslipidemias:  Familial Hypercholesterolemia & Beyond

Monday, December 14, 2020

6:00pm – Registration and Dinner

6:30 – 7:45pm – Program

Location: Chicago Marriott Magnificent Mile, Northwestern Ballroom

 

Join the NLA to solve the mystery of genetic dyslipidemias. Our panel will explore the mechanisms and manifestations of Familial Hypercholesterolemia (Heterozygous and Homozygous), Sitosterolemia, and Lysosomal Acid Lipase Deficiency. After reviewing patient profiles, you will make your diagnosis and receive real-time critiques from our panel. Before the evening is over, we will explore expert recommendations for clinical and genetic diagnosis confirmations, management strategies, and methods to maximize patient engagement throughout the life cycle.

 

Faculty
Karen E. Aspry, MD, MS, FACC, FNLA

P. Barton Duell, MD, FNLA

Don P. Wilson, MD, FNLA (Program Chair)

 

Dinner provided by the NLA

 

Late Breakers


Tuesday, December 15 

4:30 - 5:00pm

Moderator: Marlys L. Koschinsky, PhD

EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent EthylIntervention Trial 

Speaker: Michael Miller, MD, FACC, FAHA

Reductions in lipoprotein(a) with inclisiran– Analysis from ORION-10 and ORION-11

Speaker: R. Scott Wright, MD

Delete SPECIAL EVENTS

Edit Parent - PROGRAM (visibility Show)

Agenda


Sunday, December 13 , 2020
4:00PM - 6:00PM NLA Opening Session – Impact of Genetics on Clinical Practice- Chair Dr. Christie Ballantyne
4:00PM - 4:05PM Pre-Session Assessment  
4:05PM - 4:15PM Case Presentation Aliza Hussain, MD
4:15PM - 4:35PM Genetic Testing for Lipid Disorders Zahid Ahmad, MD
4:35PM - 4:55PM Polygenic Risk Scores for CVD, Use in Practice and Potential Impact on Healthcare Joshua W. Knowles, MD
4:55PM - 5:15PM My Patients are Ordering Direct-to-Consumer Genetic Testing- What Now? Emily E. Brown, MGC, CGC
5:15PM - 5:35PM Genetics and Biotech therapies Christie M. Ballantyne, MD, FNLA*
5:35PM - 5:40PM Post Session Assessment
5:40PM - 6:00PM Question & Answer Panel
6:00PM - 7:00PM Welcome Reception in Exhibit Hall
7:15PM - 9:15PM CME/CE Symposium- Dialogues from the Dais: Lipid Management in Clinical Medicine hosted by Medtelligence
This is an independent satellite CME/CE symposium held in conjunction with the NLA 2020 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.
Monday, December 14, 2020
7:00AM - 9:00AM CME/CE Symposium- The Ever-Evolving Treatment Landscape of Lipid-Lowering Therapies hosted by Medscape
This is an independent satellite CME/CE symposium held in conjunction with the NLA 2020 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.
8:00AM - 8:50AM Breakfast in Exhibit Hall
8:50AM - 9:00AM Opening Remarks
9:00AM - 10:25AM Session I- Non-Alcoholic Fatty Liver Disease and Risk of Cardiovascular Disease: What Clinicians Need to Know
9:00AM - 9:05AM Pre-Session Assessment
9:05AM - 9:15AM Case Presentation of Patient with Non-Alcoholic Fatty Liver Disease Pam R. Taub, MD
9:15AM - 9:35AM Diagnosing NAFLD and NASH in Clinical Practice and When to Refer to a Specialist John M. Vierling, MD
9:35AM - 9:50AM Evidence Based Drug Therapy Treatment Options for NAFLD Michael Wilkinson, MD
9:50AM - 10:10AM Lifestyle Interventions for NAFLD: Evaluation of the Evidence Lisa B. VanWagner, MD, MSc
10:10AM - 10:25AM Post Session Assessment and Question & Answer Panel
10:25AM - 10:30AM Intermission
10:30AM - 10:55AM NLA Presidents Address
10:55AM - 11:30AM W. Virgil Brown Distinguished Award and Lectureship John R. Guyton, MD, FNLA
11:30AM - 12:05PM Break in Exhibit Hall
12:05PM - 1:30PM Session II- Imaging Atherosclerosis: What We Know and Gaps in Knowledge
12:05PM - 12:10PM Pre-Session Assessment
12:10PM - 12:30PM Cardiac CT in 2020 Matthew J. Budoff, MD
12:30PM - 12:50PM Carotid Ultrasound and Brachial FMD James H. Stein, MD
12:50PM - 1:10PM Imaging in Pediatrics- Where we Are and Where we Need to go Elaine M. Urbina, MD, MS
1:10PM - 1:30PM Post Session Assessment and Question & Answer Panel
1:30PM - 2:40PM Lunch in Exhibit Hall
1:30PM - 2:30PM Expert Theaters
2:40PM - 4:05PM Session III- Let’s Talk About Sex…Hormones
2:40PM - 2:45PM Pre-Session Assessment
2:45PM - 3:05PM Hormone Replacement in Postmenopausal Women: Panacea or Poison? Eliot A. Brinton, MD, FNLA
3:05PM - 3:25PM Testosterone Treatment in Men Maamoun Salam, MD
3:25PM - 3:45PM Effects of Hormonal Therapy for Transgender Transition Eugenia Gianos, MD, FNLA
3:45PM - 4:05PM Post Session Assessment and Question & Answer Panel
4:05PM - 5:30PM Session IV- Prevention of Atherosclerotic Cardiovascular Disease in South Asians in the US
4:05PM - 4:10PM Pre-Session Assessment
4:10PM - 4:30PM Epidemic of ASCVD in South Asians in the US and Strategies for Early Identification Dinesh Kalra, MD
4:30PM - 4:50PM Diabetes and Heart Disease in South Asians in the US:  Challenges and Opportunities in Management Krishnaswami Vijayaraghavan, MD, MS, FNLA
4:50PM - 5:10PM Dyslipidemia in South Asians in the US Nihar R. Desai, MD, MPH
5:10PM - 5:30PM Post Session Assessment and Question & Answer Panel
6:30PM - 7:45PM CME/CE Symposium- Genetic Dyslipidemias- Familial Hypercholesterolemia and Beyond hosted by the National Lipid Association
This is an independent satellite CME/CE symposium held in conjunction with the NLA 2020 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.
8:00PM - 9:15PM New Member & Women in Lipidology Event
Tuesday, December 15, 2020
7:00AM - 9:00AM CME/CE Syposium
8:00AM - 8:50AM Breakfast in Exhibit Hall
8:50AM - 9:00AM Opening Remarks
9:00AM - 10:10AM Session V- Lipid Ball: Questions about Lipid Drugs an Interactive Audience Session
9:00AM - 9:10AM Session Overview by Chair  
9:10AM - 9:50AM Question and Answer Interactions

Ann Liebeskind, MD, FNLA
Elizabet M. Phillips, PharmD
James A. Underberg, MD, MS, FNLA
Raul D. Santos, MD, PhD

9:50AM - 10:10AM Question & Answer Panel
10:10AM - 11:00AM Break in Exhibit Hall
11:00AM - 11:50AM Session VI- Abstract Award Presentations
11:50AM - 12:20PM NLA & MWLA News and Notes/ Abstract Awards
12:20PM - 1:30PM Lunch in Exhibit Hall
12:20PM - 1:20PM Expert Theaters
1:30PM - 3:00PM Special Non-CME Joint Session between EAS and NLA- Dyslipidemia Treatment in Light of the New Guidelines- Chairs: Lale Tokgözoğlu, MD and Antonio M. Gotto, Jr., MD, DPhil, FNLA
1:30PM - 1:35PM Session Introduction from Chairs  
Targets and Goals
1:35PM - 1:50PM EAS Perspectives Alberico L. Catapano, PhD
1:50PM - 2:05PM NLA Perspectives Carl E. Orringer, MD, FNLA
Therapeutic Approaches
2:05PM - 2:50PM EAS Recommendations & Perspectives Lale Tokgözoğlu, MD
2:50PM - 2:35PM NLA Recommendations & Perspectives Peter H. Jones, MD, FNLA
2:35PM - 3:00PM Question & Answer Panel
3:00PM - 3:05PM Break
3:05PM - 4:05PM Session VII- Scientific Statements
4:05PM - 4:25PM Junior Faculty Research Award Presentation Nathan Stitziel, MD, PhD
4:25PM - 4:30PM Break
4:30PM - 5:00PM Late Breakers
5:00PM - 5:30PM VIP Fellows of the NLA Only Mixer
5:30PM - 7:00PM Honors and Awards Ceremony
7:30PM - 10:00PM Foundation of the National Lipid Association Dinner Gala & Auction
Wedensday, December 16, 2020
7:00AM - 7:50AM Breakfast
7:50AM - 8:00AM Opening Remarks
8:00AM - 9:45AM Session VIII- Cardiovascular Preventive Care in Pregnancy
8:00AM - 8:05AM Pre-Session Assessment
8:05AM - 8:25AM Who should be counseled not to get Pregnant? Combine with Review of Contraceptive planning Jennifer Thompson, MD
8:25AM - 8:45AM Medical Therapy during Pregnancy Pamela B. Morris, MD, FNLA
8:45AM - 9:05AM Medical Nutrition Therapy During High Risk Pregnancy with Severe Hypertriglyceridemia Wahida Karmally, PhD, MS, RDN, CDE, CLS
9:05AM - 9:25AM Post Session Assessment and Question & Answer Panel
9:25AM - 9:30AM Break
9:30AM - 11:15AM Session IX- Ethical Dilemmas in Lipidology
9:30AM - 9:35AM Pre-Session Assessment
9:35AM - 9:55AM CVD Risk Reduction – Is Ovum Selection Ethical for FH? James A. Trippi MD, FNLA
9:55AM - 10:15AM Can we Justify FH Genetic Testing Prior to the Age of Consent? TBA
10:15AM - 10:35AM Statins and Reproductive Health in Teens - An Accident Waiting to Happen? Ann Liebeskind MD, FNLA
10:35AM - 10:55AM Does Cholesterol Screening Potentially Limit Job Opportunities? Don P. Wilson MD, FNLA
10:55AM - 11:15AM Post Session Assessment and Question & Answer Panel
11:15AM Adjourn

 

Ancillary Courses


Foundations of Lipidology Course

Pre-conference Course

Saturday, December 12 • 8:00 am–5:35 pm

Sunday, December 13 • 8:00 am–2:30 pm

$550 NLA Members, $950 Non-Members, $0 Trainees

 

Overview

The NLA's Foundations of Lipidology course provides an introductory review of the core curriculum in Clinical Lipidology. This course is designed for any healthcare professional seeking to learn the fundamentals of Lipidology. Experts in Lipidology will lecture on basic concepts and guide participants through interactive learning scenarios that provide the knowledge and tools necessary to work effectively in a lipid practice and prepare for advanced training.

This course is particularly useful to review core elements of Clinical Lipidology and is appropriate for clinicians from the full spectrum of clinical experience including Physicians, Physician Assistants, Nurse Practitioners, Pharmacist, Exercise Physiologists, and Dietitians who are in any phase of training, or even experienced physicians who are looking to take a deeper dive into Lipidology.

The Foundations of Lipidology is offered as a two-day course prior to NLA meetings (Clinical Lipid Updates [CLU] and Scientific Sessions).

Masters in Lipidology Course

Pre-conference Course

Saturday, December 12 • 7:30 am–5:40 pm

Sunday, December 13 • 7:30 am–2:20 pm

$750 NLA Members, $1,250 Non-Members, $395 Trainees

 

Overview

The NLA's Masters in Lipidology course provides an advanced examination of the core curriculum in Clinical Lipidology. This course is designed for any health care professional with experience in Lipidology who desires advanced training. Experts in the field of Lipidology will lecture on advanced concepts and guide participants through interactive learning scenarios that provide tools and skills to further advance personal standards of practice. It is recommended that attendees have already completed preparatory coursework (e.g., Foundations of Lipidology or similar core curriculum training).

This course is particularly useful to explore the details of Clinical Lipidology and is appropriate for clinicians from the full spectrum of clinical experience including Physicians, Physician Assistants, Nurse Practitioners, Pharmacists, Exercise Physiologists, and Dietitians who are in any phase of training, or even experienced physicians who are looking to take a deeper dive into Lipidology.

Masters in Lipidology is offered as a two-day course prior to NLA meetings (Clinical Lipid Updates [CLU] and Scientific Sessions).

For additional information, click the course logo below.

For additional information, click the course logo below.

Accreditation Information


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.25 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 15.00 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL002.

Pharmacist Accreditation Statement

Universal Activity Number JA0007192-0000-20-005-L01-P (Application)
This Activity has been approved for 15.25 contact hour(s) (1.525 CEUs) of the Accreditation Council for Pharmacy Education

Nursing
The maximum number of hours awarded for this CE activity is 15.2 contact hours.

Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

 

Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses, and registered dietitians with an interest in lipid management.

Type of Activity
Live Activity, Application

Educational Objectives

At the conclusion of this activity, all participants should be able to:

  • Discuss strategies to improve the knowledge, skills or performance of the healthcare team.

NLA Opening Session: Impact of Genetics on Clinical Practice

  • Evaluate the use of genetic testing to inform risk assessment and therapeutic decisions.
  • Explain the role of the genetic counselor in screening for genetic disorders.
  • Review challenges in the application of genomic testing into clinical practice.
  • Apply insight from human genetics to identify novel therapeutic targets.

Session I: Non-Alcoholic Fatty Liver Disease and Risk of Cardiovascular Disease: What Clinicians Need to Know

  • Identify appropriate lipid management for patients with non-alcoholic fatty liver disease.
  • Review appropriate diagnostic strategies in patients with non-alcoholic fatty liver disease.
  • Determine therapeutic options for the treatment of non-alcoholic fatty liver disease.

W. Virgil Brown Distinguished Achievement Award and Lectureship

  • Evaluate the management of patients with dyslipidemia.

Session II: Imaging Atherosclerosis: What We Know and Gaps in Knowledge

  • Review the use of imaging modalities for cardiovascular risk assessment.

Session III: Let’s Talk About Sex…Hormones

  • Discuss the efficacy and safety of hormonal therapies in the management of dyslipidemia and cardiovascular risk.

Session IV: Prevention of Atherosclerotic Cardiovascular Disease in South Asians in the US

  • Recognize the risk factors and interconnection of early onset diabetes and ASCVD in South Asians.
  • Discuss epidemiology and risk profiles for dyslipidemia in South Asians in the United States.

Session V: Ask the Magic Lipid Ball: An Interactive Audience Session

  • Appraise current and emerging pharmacologic management options for dyslipidemia.

Session VI: Oral Poster Presentations

  • Critically appraise emerging research and its applications to daily clinical practice.

Special Joint Session Between EAS and NLA: Dyslipidemia Treatment in Light of the New Guidelines

  • Describe current guidelines for the management of dyslipidemia.

Session VII: Scientific Statements of the NLA

  • Review current literature of importance to the science and practice of clinical lipidology.

NLA Junior Faculty Research Award Presentation

  • Discuss the recent research impacting future management of patients with dyslipidemia.

Session VIII: Cardiovascular Preventive Care in Pregnancy

  • Discuss potential cardiovascular risks associated with pregnancy in women with genetic dyslipidemia.
  • Review strategies for managing CVD risk in pregnant women or women who plan to become pregnant.

Session IX: Ethical Dilemmas in Lipidology

  • Discuss ethical controversies in the practice of lipidology.

 

Delete PROGRAM


SCIENTIFIC MEETINGS CO-CHAIRS

Christie M. Ballantyne, MD, FNLA

Committee Co-Chair
Professor of Medicine
Vice Chair of Research for the Department of Medicine
Chief, Section of Cardiovascular Research
Chief, Section of Cardiology
Department of Medicine
Baylor College of Medicine
Houston, TX

Anne C. Goldberg, MD, FACP, FNLA

Committee Co-Chair
President, Foundation of the NLA

Professor of Medicine
Washington University School of Medicine
St. Louis, MO



PROGRAM PLANNERS

Casey Elkins, DNP, MEd, NP-C, CLS, FNLA

Program Planner
Assistant Dean for Academic Affairs
Director, DNP Program
University of South Alabama
College of Nursing
Mobile, AL

Peter H. Jones, MD, FNLA

Program Planner
Associate Professor
Baylor College of Medicine
Houston, TX

Carol Kirkpatrick, PhD, RDN, MPH, CLS, FNLA

Program Planner
Director/Clinical Associate Professor
Wellness Center
Idaho State University
Kasiska Division of Health Sciences
Pocatello, ID

Ann M. Liebeskind, MD, FNLA

President, Midwest Chapter Lipid Association
Founder
Mobile Health Team Lipids Clinic
Neenah, WI
Clinical Adjunct Assistant Professor
University of Wisconsin
School of Medicine and Public Health
Madison, WI

Pamela B. Morris, MD, FNLA

Program Planner
Director, Preventive Cardiology
Co-Director, Women’s Heart Care
Medical University of South Carolina
Mt. Pleasant, SC

Alan T. Remaley, MD, PhD

Program Planner
Section Chief Lipoprotein Metabolism Laboratory
National Heart, Lung, and Blood Institute
National Institutes of Health
Bethesda, MD

Joseph J. Saseen, PharmD, CLS, FNLA

Program Planner
President-Elect, National Lipid Association

Professor and Vice Chair
Clinical & Academic Programs
Department of Clinical Pharmacy
University of Colorado Anschutz Medical Campus
Skaggs School of Pharmacy
Aurora, CO

Daniel E. Soffer, MD, FNLA

Program Planner
University of Pennsylvania Health System
Internal Medicine/Clinical Lipidology
Perelman Center for Advanced Medicine
Philadelphia, PA



FACULTY

Zahid Ahmad, MD

Associate Professor of Internal Medicine
Co-Director, Familial Hypercholesterolemia Clinic
UT Southwestern Medical Center
Dallas, TX

Christie M. Ballantyne, MD, FNLA

Committee Co-Chair
Professor of Medicine
Vice Chair of Research for the Department of Medicine
Chief, Section of Cardiovascular Research
Chief, Section of Cardiology
Department of Medicine
Baylor College of Medicine
Houston, TX

Eliot A. Brinton, MD, FNLA

President
Utah Lipid Center
Salt Lake City, UT

Emily E. Brown, MGC, CGC

Certified Genetic Counselor
Center for Inherited Heart Disease
Johns Hopkins University
Baltimore, MD

 

 

 

Matthew J. Budoff, MD

Professor of Medicine
UCLA School of Medicine
Program Director, Cardiology
Lundquist Institute
Torrance, CA

Alberico L. Catapano, PhD

Professor of Pharmacology
Director
Center of Epidemiology and Preventive Pharmacology
Director
Laboratory of Lipoproteins, Immunity and Atherosclerosis
Department of Pharmacological and Biomolecular Sciences Director
Center for the Study of Atherosclerosis
Bassini Hospital
University of Milan                           
Milan, Italy

 

Nihar R. Desai, MD, MPH

Associate Professor of Medicine
Yale School of Medicine
Associate Chief
Section of Cardiovascular Medicine
Yale New Haven Health System
New Haven, CT

G. Kevin Donovan, MD, MA

Director
Pellegrino Center for Clinical Bioethics
Professor of Pediatrics
Georgetown University Medical Center
Washington, DC

Eugenia Gianos, MD, FNLA

System Director
Cardiovascular Prevention
Northwell Health
Director
Women's Cardiovascular Program
Lenox Hill Hospital
Associate Professor of Cardiology
Hofstra School of Medicine
New York, NY

John R. Guyton, MD, FNLA

Professor of Medicine
Assistant Professor of Pathology
Department of Medicine
Duke University School of Medicine
Durham, NC

Alizah Hussain, MD

PGY4, Lipid and Atherosclerosis Fellow
Baylor College of Medicine
Houston, TX

Peter H. Jones, MD, FNLA

Program Planner
Associate Professor
Baylor College of Medicine
Houston, TX

Dinesh Kalra, MD

Director
Lipid Clinic and Advanced Cardiac Imaging
Division of Cardiology
Rush University Medical Center
Chicago, IL

Wahida Karmally, PhD, DrPH, RDN, CDE, CLS, FNLA

Columbia University
New York, NY

Joshua W. Knowles, MD

Assistant Professor
Cardiovascular Medicine and Cardiovascular Institute
Stanford University
Chief Research Advisor
The FH Foundation
Stanford, CA

Ann M. Liebeskind, MD, FNLA

President, Midwest Chapter Lipid Association
Founder
Mobile Health Team Lipids Clinic
Neenah, WI
Clinical Adjunct Assistant Professor
University of Wisconsin
School of Medicine and Public Health
Madison, WI

Pamela B. Morris, MD, FNLA

Program Planner
Director, Preventive Cardiology
Co-Director, Women’s Heart Care
Medical University of South Carolina
Mt. Pleasant, SC

Carl E. Orringer, MD, FNLA

Associate Professor of Clinical Medicine
Director
Preventive Cardiovascular Medicine
University of Miami Miller School of Medicine
Miami, FL

Elizabeth (Lisa) Phillips, BSPharm, PharmD

Associate Professor and Chair
Pharmacy Practice and Administration
St. John Fisher College
Wegmans School of Pharmacy
Rochester, NY

Maamoun Salam, MD

Assistant Professor of Medicine
Division of Endocrinology, Metabolism and Lipid  Research
Washington University
St. Louis, MO

Raul D. Santos, MD, MSc, PhD

President, International Atherosclerosis Society
Associate Professor, Cardiology
Director
Lipid Clinic Heart Institute
University of Sao Paulo Brazil
Researcher Hospital Israelita Albert Einstein
Sao Paulo, Brazil

Joseph J. Saseen, PharmD, CLS, FNLA

Program Planner
President-Elect, National Lipid Association

Professor and Vice Chair
Clinical & Academic Programs
Department of Clinical Pharmacy
University of Colorado Anschutz Medical Campus
Skaggs School of Pharmacy
Aurora, CO

James H. Stein, MD, FNLA

Robert Turell Professor in Cardiovascular Research
Director
Atherosclerosis Imaging Research Program
University of Wisconsin
School of Medicine and Public Health
Director
Preventive Cardiology
UW Health
Madison, WI

Nathan O. Stitziel, MD, PhD

Associate Professor of Medicine and Genetics
Director
Center for Cardiovascular Genetics
Washington University School of Medicine
St. Louis, MO

Pam R. Taub, MD

Director
Step Family Foundation Cardiovascular Rehabilitation and Wellness Center
Associate Professor of Medicine
Department of Cardiovascular Medicine
University of California, San Diego
La Jolla, CA

Jennifer L. Thompson, MD

Assistant Professor Obstetrics and Gynecology
Fellowship Program Director
Maternal Fetal Medicine
Vanderbilt University Medical Center
Nashville, TN

Lale Tokgözoğlu, MD

President, European Atherosclerosis Society
Professor of Cardiology
Hacettepe University
Ankara, Turkey

James A. Trippi, MD, FNLA

Director
Complex Cholesterol Center
Cardiometabolic Center
Ascension- St. Vincent Health
Indianapolis, IN

James A. Underberg, MD, MS, FNLA

Past- President, National Lipid Association
Clinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for Prevention of Cardiovascular Disease
Director
Bellevue Hospital Lipid Clinic
New York, NY

Elaine M. Urbina, MD, MS

Director
Preventive Cardiology
Cincinnati Children's Hospital Medical Center
Cincinnati, OH

John M. Vierling, MD

Professor of Medicine and Surgery
Chief of Hepatology
Director of Advanced Liver Therapies
Baylor College of Medicine
Houston, TX

Krishnaswami Vijayaraghavan, MD, MS, FNLA

Executive Council Chair, National Lipid Association
Medical Director
CHF, Abrazo Health Network
Clinical Professor of Medicine
University of Arizona
Phoenix, AZ

Michael Wilkinson, MD

Assistant Professor of Medicine
Division of Cardiovascular Medicine
University of California, San Diego
La Jolla, CA

Don P. Wilson, MD, FNLA

Director
Pediatric CV Health and Risk Reduction
Cook Children’s Medical Center’
Fort Worth, TX



Register for 2020 Scientific Sessions

Registration Options






NLA Member Pricing
*Must be logged in


Main Session Earlybird Price!

December 13-16, 2020


Masters in Lipidology

Decembere 12-13, 2020


Foundations of Lipidology

December 12-13, 2020


Non-Member Pricing


Main Session

December 13-16, 2020

OR

Join the NLA and save on registration

$195.00 NLA Member Applicaton + $695.00 Main Session Registration - $50.00 New Member Discount

Masters in Lipidology

Decembere 12-13, 2020


Foundations of Lipidology

December 12-13, 2020


Trainee Pricing
*Must be logged in


Main Session

December 13-16, 2020


Masters in Lipidology

Decembere 12-13, 2020


Foundations of Lipidology

December 12-13, 2020

$ 0.00


Add-ons


Guest Ticket



Interested in the Trainee Rate?


Enrolled in a graduate or postgraduate training program and want to attend at the Trainee Member rate?

Apply now for free





Disclaimer


Lipid Bucks: Lipid Bucks can be applied on the checkout page.

Registration: Online registration and payment must be received no later than December 12, 2020. After this date, meeting materials and name badge cannot be guaranteed, but onsite registration will be available until December 16, 2020. By registering for this meeting, attendee understands and agrees that attendee’s name, city, and state may be shared with other attendees and exhibitors. By allowing an exhibitor to scan the conference badge, attendee understands, agrees and consents to the sharing of attendee’s contact information with the company that scanned the conference badge.

Photography: Photographs and/or video may be taken as part of the registered event. By registering for this event, you grant the National Lipid Association full rights to use the images resulting from the photography/video filming and any reproductions or adaptations of the images for promotional purposes. This may include (but is not limited to), the right to use them in print and online platforms, social media, press releases and other outlets.

Cancellation: Telephone cancellations will not be accepted. A written notice of cancellation must be received no later than November 4, 2020. This includes social events and guest fees. There will be a $100 fee for all cancellations. There will be no refunds if cancelling within 30 days of the start of the meeting date.

Attendees who need special reasonable accommodations or who have special needs should contact the meeting organizers at 904-998-0854.